Mitochondrial reactive oxygen species mediate cardiomyocyte formation from embryonic stem cells in high glucose
- PMID: 20506541
- DOI: 10.1002/stem.441
Mitochondrial reactive oxygen species mediate cardiomyocyte formation from embryonic stem cells in high glucose
Abstract
Accumulating evidence points to reactive oxygen species (ROS) as important signaling molecules for cardiomyocyte differentiation in embryonic stem (ES) cells. Given that ES cells are normally maintained and differentiated in medium containing supraphysiological levels of glucose (25 mM), a condition which is known to result in enhanced cellular ROS formation, we questioned whether this high glucose concentration was necessary for cardiomyocyte lineage potential. We show here that ES cells cultured in physiological glucose (5 mM), maintained their general stemness qualities but displayed an altered mitochondrial metabolism, which resulted in decreased ROS production. Furthermore, ES and induced pluripotent stem (iPS) cells differentiated in lower glucose concentrations failed to generate cardiomyocyte structures; an effect mimicked with antioxidant treatments using catalase, N-acetyl cysteine and mitoubiquinone, under high glucose conditions in ES cells. Molecular analysis revealed that ES cells differentiated in 5 mM glucose had reduced expression of the pro-cardiac NOX4 gene and diminished phosphorylation of p38 mitogen-activated protein kinase (MAPK), together with specific changes in the cardiac transcriptional network. These outcomes could be reversed by supplementation of low glucose cultures with ascorbic acid, paradoxically acting as a pro-oxidant. Furthermore, forced expression of an upstream p38 MAPK kinase (MKK6) could bypass the requirement for ROS during differentiation to cardiomyocytes under low glucose conditions, illustrating a key role for p38 in the cardiac differentiation program. Together these data demonstrate that endogenous ROS control is important for cardiomyocyte formation from ES cells, and furthermore that supraphysiological glucose, by supplying ROS, is absolutely required.
Similar articles
-
Stimulation of ES-cell-derived cardiomyogenesis and neonatal cardiac cell proliferation by reactive oxygen species and NADPH oxidase.J Cell Sci. 2007 Mar 1;120(Pt 5):885-94. doi: 10.1242/jcs.03386. Epub 2007 Feb 13. J Cell Sci. 2007. PMID: 17298980
-
Time-dependence of cardiomyocyte differentiation disturbed by peroxisome proliferator-activated receptor alpha inhibitor GW6471 in murine embryonic stem cells in vitro.Acta Pharmacol Sin. 2007 May;28(5):634-42. doi: 10.1111/j.1745-7254.2007.00558.x. Acta Pharmacol Sin. 2007. PMID: 17439719
-
p38 mitogen-activated protein kinase activity commits embryonic stem cells to either neurogenesis or cardiomyogenesis.Stem Cells. 2006 May;24(5):1399-406. doi: 10.1634/stemcells.2005-0398. Epub 2006 Jan 19. Stem Cells. 2006. PMID: 16424397
-
Protocols for cardiac differentiation of embryonic stem cells.Methods. 2008 Jun;45(2):168-71. doi: 10.1016/j.ymeth.2008.03.003. Epub 2008 May 29. Methods. 2008. PMID: 18593613 Review.
-
[Review of basic studies about the cardiac stem cell and regenerative medicine].Nihon Rinsho. 2008 May;66(5):908-14. Nihon Rinsho. 2008. PMID: 18464509 Review. Japanese.
Cited by
-
Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal.Cell Stem Cell. 2012 Nov 2;11(5):589-95. doi: 10.1016/j.stem.2012.10.005. Cell Stem Cell. 2012. PMID: 23122286 Free PMC article.
-
Real-time monitoring of specific oxygen uptake rates of embryonic stem cells in a microfluidic cell culture device.Biotechnol J. 2016 Sep;11(9):1179-89. doi: 10.1002/biot.201500479. Epub 2016 Jun 22. Biotechnol J. 2016. PMID: 27214658 Free PMC article.
-
Manipulation of Pluripotent Stem Cell Metabolism for Clinical Application.Curr Stem Cell Rep. 2017;3(1):28-34. doi: 10.1007/s40778-017-0073-9. Epub 2017 Feb 13. Curr Stem Cell Rep. 2017. PMID: 28261548 Free PMC article. Review.
-
Monitoring Mitochondrial Function in Mouse Embryonic Stem Cells (mESCs).Methods Mol Biol. 2021;2310:47-56. doi: 10.1007/978-1-0716-1433-4_4. Methods Mol Biol. 2021. PMID: 34095997
-
The challenges and optimization of cell-based therapy for cardiovascular disease.J Transl Int Med. 2021 Dec 31;9(4):234-238. doi: 10.2478/jtim-2021-0017. eCollection 2021 Dec 1. J Transl Int Med. 2021. PMID: 35136722 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous